Portfolio (Quarterly)
Guide ↗
RTW INVESTMENTS, LP
· CIK 0001493215| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 3,685,045.0 | $148.2M | 1.48% | -4.0M | -51.9% | $40.23 | +2.0% |
| 22 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 4,869,798.0 | $146.8M | 1.46% | — | — | $30.15 | -4.6% |
| 23 | RGEN | REPLIGEN CORP | Healthcare | 1,206,000.0 | $142.1M | 1.41% | +142K | +13.3% | $117.82 | -12.3% |
| 24 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 1,062,072.0 | $139.9M | 1.39% | — | — | $131.74 | +20.7% |
| 25 | GH | GUARDANT HEALTH INC | Healthcare | 1,481,033.0 | $136.8M | 1.36% | — | — | $92.37 | +6.8% |
| 26 | IMTX | IMMATICS N.V | Healthcare | 12,869,340.0 | $126.6M | 1.26% | +1.4M | +12.6% | $9.84 | +13.5% |
| 27 | ZLAB | ZAI LAB LTD | Healthcare | 6,574,032.0 | $123.7M | 1.23% | -385K | -5.5% | $18.81 | +8.1% |
| 28 | BLTE | BELITE BIO INC | Healthcare | 715,332.0 | $114.1M | 1.14% | — | — | $159.44 | -10.3% |
| 29 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 220,000.0 | $101.4M | 1.01% | +119K | +117.3% | $460.99 | -7.1% |
| 30 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 2,058,148.0 | $101.0M | 1.00% | — | — | $49.05 | +30.3% |
| 31 | GHRS | GH RESEARCH PLC | Healthcare | 5,933,815.0 | $83.4M | 0.83% | — | — | $14.06 | +58.0% |
| 32 | XNCR | XENCOR INC | Healthcare | 6,777,461.0 | $81.7M | 0.81% | — | — | $12.06 | -1.5% |
| 33 | URGN | UROGEN PHARMA LTD | Healthcare | 4,543,895.0 | $81.7M | 0.81% | — | — | $17.98 | +65.1% |
| 34 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 2,054,175.0 | $81.6M | 0.81% | +263K | +14.7% | $39.72 | -0.3% |
| 35 | IMVT | IMMUNOVANT INC | Healthcare | 3,177,849.0 | $78.9M | 0.79% | — | — | $24.84 | +16.6% |
| 36 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3,648,795.0 | $76.4M | 0.76% | +649K | +21.6% | $20.95 | +23.2% |
| 37 | HNGE | HINGE HEALTH INC | Healthcare | 1,930,000.0 | $74.4M | 0.74% | +1.6M | +446.0% | $38.56 | +39.7% |
| 38 | CSTL | CASTLE BIOSCIENCES INC | Healthcare | 2,758,335.0 | $67.7M | 0.67% | +643K | +30.4% | $24.55 | -23.1% |
| 39 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 17,687,772.0 | $63.3M | 0.63% | — | — | $3.58 | -5.0% |
| 40 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 13,680,248.0 | $61.2M | 0.61% | -2.7M | -16.6% | $4.47 | +40.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%